SCHEMBL6955587

SCHEMBL6955587

Cc1ccc(C(=O)NC(C)(C)C)cc1N=O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.43
POLB P06746 1/20 0.43
IMPDH2 P12268 1/20 0.42
SIRT2 Q8IXJ6 1/20 0.42
MAPK14 Q16539 1/20 0.40
LMNA P02545 4/20 0.39
ALDH1A1 P00352 2/20 0.39
KMT2A Q03164 2/20 0.39
GAA P10253 1/20 0.39
CYP2C19 P33261 2/20 0.39
HTT P42858 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
PRKAB2 O43741 1/20 0.38
PRKAG1 P54619 1/20 0.38
PRKAA2 P54646 1/20 0.38
PRKAA1 Q13131 1/20 0.38
PRKAG3 Q9UGI9 1/20 0.38
PRKAG2 Q9UGJ0 1/20 0.38
PRKAB1 Q9Y478 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14867646 0.81 KMT2A (0.51) MAPTPOLBIMPDH2SIRT2ALDH1A1
SCHEMBL13701820 0.77 MTOR (0.50) MAPTPOLBIMPDH2SIRT2MAPK14
SCHEMBL13240435 0.77 CHRNA1 (0.59) MAPTPOLBKMT2AGAAMEN1
SCHEMBL12037438 0.75 CYP2A6 (0.44) MAPTLMNAALDH1A1KMT2ARAB9A
SCHEMBL10079468 0.75 MAPT (0.51) MAPTPOLBLMNAALDH1A1KMT2A
SCHEMBL85865 0.75 CA1 (0.50) MAPTLMNAALDH1A1KMT2AGAA
SCHEMBL16976360 0.74 GABRA1 (0.43) MAPTLMNAALDH1A1KMT2ACYP2C19
SCHEMBL6997419 0.74 TAS1R3 (0.52) MAPTPOLBIMPDH2ALDH1A1KMT2A
SCHEMBL17865779 0.74 LMNA (0.58) MAPTPOLBSIRT2LMNAHTT
SCHEMBL14707993 0.74 HDAC1 (0.43) MAPTPOLBLMNAALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8183293-B2 Phenyl acetic acid derivatives AMGEN INC. (US) 2012-05-22 US disclosed
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators AMGEN INC. (US) 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275659-A1 Phenyl acetic acid derivatives as inflammation modulators NFKBIA, HCAR2, NFATC1 MAPT 538/4885POLB 3980/4885IMPDH2 3222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.